Muhammad Akbar Ramadhan Munandar, Hendra Priatna Munandar, Liana Herlina. Cost-Effectiveness of Pembrolizumab as First-Line Treatment for PD-L1 Positive NSCLC: A Systematic Review. the int. j. of med. science and health. 2026;23(2):64-130. doi:10.70070/h3zdy035